MedPath

Clinical Efficacy of OneTouch® Verio™IQ Meter

Not Applicable
Completed
Conditions
Diabetes Mellitus
Registration Number
NCT02521506
Lead Sponsor
Fundación Pública Andaluza Progreso y Salud
Brief Summary

Diabetes mellitus is one of the most prevalent disease in the western world. The control of glucose levels has a big impact in the prevention of diabetes complications. The measure of glucose levels in capillary blood with glucometers is the gold standard to measure and control the glucose levels. Nowadays the glucometers become to more precise and sophisticated devices. One of the most notables advance is the inclusion of software that cam predicts glucose trends. This software has not be tested in routine clinical practice.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Patient diagnosed with diabetes mellitus 1 or 2
  • Treatment with insulin regimen during at least 12 months
  • Capability of performed 3 glucose measurement per day
  • Levels of glycated hemoglobin (A1C) less than 10%
Exclusion Criteria
  • Patients diagnosed of mental disorders
  • Patients included in structured therapeutic health 6 months before the inclusion
  • Patients included in any clinical trial in the 4 months before the inclusion

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
number of hypoglycemic events20 months

Glucose levels under 70 mg/dL with or without clinical manifestation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Complejo Hospitalario Universitario A Coruña

🇪🇸

A Coruña, Spain

Hospital Universitario Torrecárdenas

🇪🇸

Almería, Spain

Hospital Clínico San Carlos

🇪🇸

Madrid, Spain

Hospital Universitario Virgen de la Victoria

🇪🇸

Málaga, Spain

Complejo Hospitalario Universitario A Coruña
🇪🇸A Coruña, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.